The First Year: Age-Related Macular Degeneration

Foreword by Lylas G. Mogk, MD

Also available from:

On Sale: Aug 29, 2006
Page Count: 352 pages
Publisher: Balance
ISBN-13: 9781569242865

Age-related macular degeneration (AMD) is a progressive disease of the retina that develops when the light-sensing cells in the central area of vision (the macula) stop working and eventually die. Thought to be caused by a combination of genetic and environmental factors, the disease is the leading cause of blindness in people over 50. In 1995, Dan Roberts retired from teaching to help others who also suffered from macular degeneration. Roberts has established support networks for AMD patients and provided free presentations about vision impairment at schools, community organizations, and support groups across the country. The First Year: Age-Related Macular Degeneration is an essential resource for those who want to be an informed, active participant in the management of their condition.

Genre:

Series:

The First Year

$21.99

$28.99 CAD

Format

Trade Paperback

Format:

Trade Paperback $21.99 $28.99 CAD

By clicking ‘Sign Up,’ I acknowledge that I have read and agree to Hachette Book Group’s Privacy Policy and Terms of Use

Daniel L. Roberts

About the Author

Dan Roberts is a visually-impaired educator and musician who has spent the past twelve years devoted to researching and helping others with age-related macular degeneration. Roberts is the recipient of the 2004 Distinguished Service Award presented by the American Optometric Association Low Vision Rehabilitation Section. His organization was also awarded the National Eye Institute’s 2006 Healthy Vision Community Award for innovative approaches to vision-related health education. He lives in Grandview, Missouri.

Lylas G. Mogk, M.D., is an ophthalmologist, Medical Director of the Henry Ford Health System Visual Rehabilitation and Research Center, in Grosse Pointe and Livonia, Michigan, co-author of Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight, and Chair of the American Academy of Ophthalmology Vision Rehabilitation Committee.

Learn more about this author